Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Alloy Therapeutics Partners with Biogen on Multi-Target Antisense Drug Development

Wednesday, April 08, 2026

Alloy Therapeutics has entered into a collaboration and licence agreement with Biogen to support the development of antisense therapies across multiple undisclosed targets

Gilead to Acquire Tubulis to Strengthen Oncology Pipeline with Next-Generation ADC Platform

Wednesday, April 08, 2026

Gilead Sciences has entered into a definitive agreement to acquire TubulisThe move is aimed at strengthening Gileads oncology pipeline and addressing areas of high unmet medical need

China’s NMPA Releases Revised Medical Device GMP Effective November 2026 Impacting Asia Life Sciences Manufacturing

Tuesday, April 07, 2026

Chinas National Medical Products Administration has issued a revised Good Manufacturing Practice guideline for medical devices set to take effect November enhancing quality standards across Asias supply chains

Akari Therapeutics Partners with WuXi XDC to Advance RNA Splicing ADC Payload

Tuesday, April 07, 2026

Akari Therapeutics has entered into a strategic partnership with WuXi XDC to accelerate the development of its novel antibodydrug conjugate ADC payload PH which targets RNA splicing

Shimadzu Scientific Instruments Opens New Laboratory in San Francisco Bay Area to Boost Asia-Pacific Life Sciences Innovation

Friday, April 03, 2026

Shimadzu Scientific Instruments has inaugurated a new advanced laboratory in the San Francisco Bay Area enhancing its support for life sciences research and pharma manufacturing across AsiaPacific markets

China's Frontier Biotechnologies Signs $950M Global Licensing Deal with GSK for siRNA Kidney Disease Drugs

Thursday, April 02, 2026

Frontier Biotechnologies inks a landmark global exclusive licensing agreement with GSK for two siRNA drug candidates targeting kidney diseases securing M upfront and up to M in milestones

Zai Lab Enters into Collaboration with Amgen to Evaluate DLL3 ADC Zocilurtatug Pelitecan with BiTE Therapy in Small Cell Lung Cancer

Thursday, April 02, 2026

Zai Lab has announced a global clinical trial collaboration and supply agreement with Amgen to evaluate its investigational DLLtargeting antibodydrug conjugate ADC zocilurtatug pelitecan

FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib in CNS Tumours

Thursday, April 02, 2026

FORE Biotherapeutics has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to plixorafenib for the treatment of adult patients with BRAF VEmutated highgrade glioma HGG

China Biopharma's $56.7B Deal Boom Signals Pillar Industry Dominance in 2026

Wednesday, April 01, 2026

Chinese innovative drug outlicensing deals have surged since early totaling billion across agreements underscoring Chinas rising dominance in global biopharma

Infinimmune Enters into Collaboration with Merck to Advance Human Antibody Discovery

Wednesday, April 01, 2026

Infinimmune has entered into a collaboration with Merck MSD outside the United States and Canada to discover and develop novel human antibody therapeutics across multiple undisclosed targets